1 5820 128 STRESS DYNAMICALLY REGULATES BEHAVIOR AND GLUTAMATERGIC GENE EXPRESSION IN HIPPOCAMPUS BY OPENING A WINDOW OF EPIGENETIC PLASTICITY. EXCITATORY AMINO ACIDS PLAY A KEY ROLE IN BOTH ADAPTIVE AND DELETERIOUS EFFECTS OF STRESSORS ON THE BRAIN, AND DYSREGULATED GLUTAMATE HOMEOSTASIS HAS BEEN ASSOCIATED WITH PSYCHIATRIC AND NEUROLOGICAL DISORDERS. HERE, WE ELUCIDATE MECHANISMS OF EPIGENETIC PLASTICITY IN THE HIPPOCAMPUS IN THE INTERACTIONS BETWEEN A HISTORY OF CHRONIC STRESS AND FAMILIAR AND NOVEL ACUTE STRESSORS THAT ALTER EXPRESSION OF ANXIETY- AND DEPRESSIVE-LIKE BEHAVIORS. WE DEMONSTRATE THAT ACUTE RESTRAINT AND ACUTE FORCED SWIM STRESSORS INDUCE DIFFERENTIAL EFFECTS ON THESE BEHAVIORS IN NAIVE MICE AND IN MICE WITH A HISTORY OF CHRONIC-RESTRAINT STRESS (CRS). THEY REVEAL A KEY ROLE FOR EPIGENETIC UP- AND DOWN-REGULATION OF THE PUTATIVE PRESYNAPTIC TYPE 2 METABOTROPIC GLUTAMATE (MGLU2) RECEPTORS AND THE POSTSYNAPTIC NR1/NMDA RECEPTORS IN THE HIPPOCAMPUS AND PARTICULARLY IN THE DENTATE GYRUS (DG), A REGION OF ACTIVE NEUROGENESIS AND A TARGET OF ANTIDEPRESSANT TREATMENT. WE SHOW CHANGES IN DG LONG-TERM POTENTIATION (LTP) THAT PARALLEL BEHAVIORAL RESPONSES, WITH HABITUATION TO THE SAME ACUTE RESTRAINT STRESSOR AND SENSITIZATION TO A NOVEL FORCED-SWIM STRESSOR. IN WT MICE AFTER CRS AND IN UNSTRESSED MICE WITH A BDNF LOSS-OF-FUNCTION ALLELE (BDNF VAL66MET), WE SHOW THAT THE EPIGENETIC ACTIVATOR OF HISTONE ACETYLATION, P300, PLAYS A PIVOTAL ROLE IN THE DYNAMIC UP- AND DOWN-REGULATION OF MGLU2 IN HIPPOCAMPUS VIA HISTONE-3-LYSINE-27-ACETYLATION (H3K27AC) WHEN ACUTE STRESSORS ARE APPLIED. THESE HIPPOCAMPAL RESPONSES REVEAL A WINDOW OF EPIGENETIC PLASTICITY THAT MAY BE USEFUL FOR TREATMENT OF DISORDERS IN WHICH GLUTAMATERGIC TRANSMISSION IS DYSREGULATED. 2015 2 2513 32 EPIGENETICS AND PSYCHOSTIMULANT ADDICTION. CHRONIC DRUG EXPOSURE ALTERS GENE EXPRESSION IN THE BRAIN AND PRODUCES LONG-TERM CHANGES IN NEURAL NETWORKS THAT UNDERLIE COMPULSIVE DRUG TAKING AND SEEKING. EXACTLY HOW DRUG-INDUCED CHANGES IN SYNAPTIC PLASTICITY AND SUBSEQUENT GENE EXPRESSION ARE TRANSLATED INTO PERSISTENT NEUROADAPTATIONS REMAINS UNCLEAR. EMERGING EVIDENCE SUGGESTS THAT COMPLEX DRUG-INDUCED NEUROADAPTATIONS IN THE BRAIN ARE MEDIATED BY HIGHLY SYNCHRONIZED AND DYNAMIC PATTERNS OF GENE REGULATION. RECENTLY, IT HAS BECOME CLEAR THAT EPIGENETIC MECHANISMS CONTRIBUTE TO DRUG-INDUCED STRUCTURAL, SYNAPTIC, AND BEHAVIORAL PLASTICITY BY REGULATING EXPRESSION OF GENE NETWORKS. HERE WE REVIEW HOW ALTERATIONS IN HISTONE MODIFICATIONS, DNA METHYLATION, AND MICRORNAS REGULATE GENE EXPRESSION AND CONTRIBUTE TO PSYCHOSTIMULANT ADDICTION WITH A FOCUS ON THE EPIGENETIC MECHANISMS THAT REGULATE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) EXPRESSION FOLLOWING CHRONIC COCAINE EXPOSURE. IDENTIFYING EPIGENETIC SIGNATURES THAT DEFINE PSYCHOSTIMULANT ADDICTION MAY LEAD TO NOVEL, EFFICACIOUS TREATMENTS FOR DRUG CRAVING AND RELAPSE. 2013 3 4222 30 METHYLATION AT THE CPG ISLAND SHORE REGION UPREGULATES NR3C1 PROMOTER ACTIVITY AFTER EARLY-LIFE STRESS. EARLY-LIFE STRESS (ELS) INDUCES LONG-LASTING CHANGES IN GENE EXPRESSION CONFERRING AN INCREASED RISK FOR THE DEVELOPMENT OF STRESS-RELATED MENTAL DISORDERS. GLUCOCORTICOID RECEPTORS (GR) MEDIATE THE NEGATIVE FEEDBACK ACTIONS OF GLUCOCORTICOIDS (GC) IN THE PARAVENTRICULAR NUCLEUS (PVN) OF THE HYPOTHALAMUS AND ANTERIOR PITUITARY AND THEREFORE PLAY A KEY ROLE IN THE REGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS AND THE ENDOCRINE RESPONSE TO STRESS. WE HERE SHOW THAT ELS PROGRAMS THE EXPRESSION OF THE GR GENE (NR3C1) BY SITE-SPECIFIC HYPERMETHYLATION AT THE CPG ISLAND (CGI) SHORE IN HYPOTHALAMIC NEURONS THAT PRODUCE CORTICOTROPIN-RELEASING HORMONE (CRH), THUS PREVENTING CRH UPREGULATION UNDER CONDITIONS OF CHRONIC STRESS. CPGS MAPPING TO THE NR3C1 CGI SHORE REGION ARE DYNAMICALLY REGULATED BY ELS AND UNDERPIN METHYLATION-SENSITIVE CONTROL OF THIS REGION'S INSULATION-LIKE FUNCTION VIA YING YANG 1 (YY1) BINDING. OUR RESULTS PROVIDE NEW INSIGHT INTO HOW A GENOMIC ELEMENT INTEGRATES EXPERIENCE-DEPENDENT EPIGENETIC PROGRAMMING OF THE COMPOSITE PROXIMAL NR3C1 PROMOTER, AND ASSIGNS AN INSULATING ROLE TO THE CGI SHORE. 2015 4 2596 35 EPIGENETICS OF STRESS ADAPTATIONS IN THE BRAIN. RECENT FINDINGS IN EPIGENETICS SHED NEW LIGHT ON THE REGULATION OF GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM (CNS) DURING STRESS. THE MOST FREQUENTLY STUDIED EPIGENETIC MECHANISMS ARE DNA METHYLATION, HISTONE MODIFICATIONS AND MICRORNA ACTIVITY. THESE MECHANISMS STABLY DETERMINE CELL PHENOTYPE BUT CAN ALSO BE RESPONSIBLE FOR DYNAMIC MOLECULAR ADAPTATIONS OF THE CNS TO STRESSORS. THE LIMBIC-HYPOTHALAMIC-PITUITARY-ADRENAL AXIS (LHPA) IS THE PRIMARY CIRCUIT THAT INITIATES, REGULATES AND TERMINATES A STRESS RESPONSE. THE SAME BRAIN AREAS THAT CONTROL STRESS ALSO REACT TO STRESS DYNAMICALLY AND WITH LONG-TERM CONSEQUENCES. ONE OF THE BIOLOGICAL PROCESSES EVOKING POTENT ADAPTIVE CHANGES IN THE CNS SUCH AS CHANGES IN BEHAVIOR, GENE ACTIVITY OR SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS IS PSYCHOGENIC STRESS. THIS REVIEW SUMMARIZES THE CURRENT DATA REGARDING THE EPIGENETIC BASIS OF MOLECULAR ADAPTATIONS IN THE BRAIN INCLUDING GENOME-WIDE EPIGENETIC CHANGES OF DNA METHYLATION AND PARTICULAR GENES INVOLVED IN EPIGENETIC RESPONSES THAT PARTICIPATE IN THE BRAIN RESPONSE TO CHRONIC PSYCHOGENIC STRESSORS. IT IS CONCLUDED THAT SPECIFIC EPIGENETIC MECHANISMS IN THE CNS ARE INVOLVED IN THE STRESS RESPONSE. 2013 5 243 37 ADOLESCENT CHRONIC INTERMITTENT TOLUENE INHALATION DYNAMICALLY REGULATES THE TRANSCRIPTOME AND NEURONAL METHYLOME WITHIN THE RAT MEDIAL PREFRONTAL CORTEX. INHALANTS CONTAINING THE VOLATILE SOLVENT TOLUENE ARE MISUSED TO INDUCE EUPHORIA OR INTOXICATION. INHALANT ABUSE IS MOST COMMON DURING ADOLESCENCE AND CAN RESULT IN COGNITIVE IMPAIRMENTS DURING AN IMPORTANT MATURATIONAL PERIOD. DESPITE EVIDENCE SUGGESTING THAT EPIGENETIC MODIFICATIONS MAY UNDERPIN THE COGNITIVE EFFECTS OF INHALANTS, NO STUDIES TO DATE HAVE THOROUGHLY INVESTIGATED TOLUENE-INDUCED REGULATION OF THE TRANSCRIPTOME OR DISCRETE EPIGENETIC MODIFICATIONS WITHIN THE BRAIN. TO ADDRESS THIS, WE INVESTIGATED EFFECTS OF ADOLESCENT CHRONIC INTERMITTENT TOLUENE (CIT) INHALATION ON GENE EXPRESSION AND DNA METHYLATION PROFILES WITHIN THE RAT MEDIAL PREFRONTAL CORTEX (MPFC), WHICH UNDERGOES MATURATION THROUGHOUT ADOLESCENCE AND HAS BEEN IMPLICATED IN TOLUENE-INDUCED COGNITIVE DEFICITS. EMPLOYING BOTH RNA-SEQ AND GENOME-WIDE METHYL CPG BINDING DOMAIN (MBD) ULTRA-SEQ ANALYSIS, WE DEMONSTRATE THAT ADOLESCENT CIT INHALATION (10 000 PPM FOR 1 H/DAY, 3 DAYS/WEEK FOR 4 WEEKS) INDUCES BOTH TRANSIENT AND PERSISTENT CHANGES TO THE TRANSCRIPTOME AND DNA METHYLOME WITHIN THE RAT MPFC FOR AT LEAST 2 WEEKS FOLLOWING TOLUENE EXPOSURE. WE DEMONSTRATE FOR THE FIRST TIME THAT ADOLESCENT CIT EXPOSURE RESULTS IN DYNAMIC REGULATION OF THE MPFC TRANSCRIPTOME LIKELY RELATING TO ACUTE INFLAMMATORY RESPONSES AND PERSISTENT DEFICITS IN SYNAPTIC PLASTICITY. THESE ADAPTATIONS MAY CONTRIBUTE TO THE COGNITIVE DEFICITS ASSOCIATED WITH CHRONIC TOLUENE EXPOSURE AND PROVIDE NOVEL MOLECULAR TARGETS FOR PREVENTING LONG-TERM NEUROPHYSIOLOGICAL ABNORMALITIES FOLLOWING CHRONIC TOLUENE INHALATION. 2021 6 2325 36 EPIGENETIC REGULATION OF HIPPOCAMPAL FOSB EXPRESSION CONTROLS BEHAVIORAL RESPONSES TO COCAINE. DRUG ADDICTION RESULTS IN PART FROM MALADAPTIVE LEARNING, INCLUDING THE FORMATION OF STRONG ASSOCIATIONS BETWEEN THE DRUG AND THE CIRCUMSTANCES OF CONSUMPTION. HOWEVER, DRUG-INDUCED CHANGES IN GENE EXPRESSION UNDERLYING THE SALIENCY OF THESE ASSOCIATIONS REMAIN UNDERSTUDIED. CONSOLIDATION OF EXPLICIT MEMORIES OCCURS WITHIN THE HIPPOCAMPUS, AND WE HAVE SHOWN THAT SPATIAL LEARNING INDUCES EXPRESSION OF THE TRANSCRIPTION FACTOR DELTAFOSB IN HIPPOCAMPUS AND THAT THIS INDUCTION IS CRITICAL FOR LEARNING. DRUGS OF ABUSE ALSO UPREGULATE DELTAFOSB IN HIPPOCAMPUS, BUT THE MECHANISM OF ITS INDUCTION BY COCAINE AND ITS ROLE IN HIPPOCAMPUS-DEPENDENT COCAINE RESPONSES IS UNKNOWN. WE INVESTIGATED DIFFERENCES IN MOUSE DORSAL AND VENTRAL HIPPOCAMPAL DELTAFOSB EXPRESSION IN RESPONSE TO CHRONIC COCAINE, BECAUSE THESE REGIONS APPEAR TO REGULATE DISTINCT COCAINE-RELATED BEHAVIORS. WE FOUND THAT COCAINE-MEDIATED INDUCTION OF DELTAFOSB WAS SUBREGION-SPECIFIC, AND THAT DELTAFOSB TRANSCRIPTIONAL ACTIVITY IN BOTH THE DORSAL AND VENTRAL HIPPOCAMPUS IS NECESSARY FOR COCAINE CONDITIONED PLACE PREFERENCE. FURTHER, WE CHARACTERIZE CHANGES IN HISTONE MODIFICATIONS AT THE FOSB PROMOTER IN HIPPOCAMPUS IN RESPONSE TO CHRONIC COCAINE AND FOUND THAT LOCUS-SPECIFIC EPIGENETIC MODIFICATION IS ESSENTIAL FOR FOSB INDUCTION AND MULTIPLE HIPPOCAMPUS-DEPENDENT BEHAVIORS, INCLUDING COCAINE PLACE PREFERENCE. COLLECTIVELY, THESE FINDINGS SUGGEST THAT EXPOSURE TO COCAINE INDUCES HISTONE MODIFICATION AT THE HIPPOCAMPAL FOSB GENE PROMOTER TO CAUSE DELTAFOSB INDUCTION CRITICAL FOR COCAINE-RELATED LEARNING.SIGNIFICANCE STATEMENT ALTHOUGH COCAINE ADDICTION IS DRIVEN IN PART BY THE FORMATION OF INDELIBLE ASSOCIATIONS BETWEEN THE DRUG AND THE ENVIRONMENT, PARAPHERNALIA, AND CIRCUMSTANCES OF USE, AND ALTHOUGH THIS TYPE OF ASSOCIATIVE LEARNING IS DEPENDENT UPON CHANGES IN GENE EXPRESSION IN A BRAIN REGION CALLED THE HIPPOCAMPUS, THE MECHANISMS BY WHICH COCAINE ALTERS HIPPOCAMPAL GENE EXPRESSION TO DRIVE FORMATION OF THESE ASSOCIATIONS IS POORLY UNDERSTOOD. HERE, WE DEMONSTRATE THAT CHRONIC COCAINE ENGAGES LOCUS-SPECIFIC CHANGES IN THE EPIGENETIC PROFILE OF THE FOSB GENE IN THE HIPPOCAMPUS, AND THAT THESE ALTERATIONS ARE REQUIRED FOR COCAINE-DEPENDENT GENE EXPRESSION AND COCAINE-ENVIRONMENT ASSOCIATIONS. THIS WORK PROVIDES NOVEL INSIGHT INTO ADDICTION ETIOLOGY AND POTENTIAL INROADS FOR THERAPEUTIC INTERVENTION IN COCAINE ADDICTION. 2019 7 1532 19 DNA METHYLATION DYNAMICS AND COCAINE IN THE BRAIN: PROGRESS AND PROSPECTS. CYTOSINE MODIFICATIONS, INCLUDING DNA METHYLATION, ARE STABLE EPIGENETIC MARKS THAT MAY TRANSLATE ENVIRONMENTAL CHANGE INTO TRANSCRIPTIONAL REGULATION. RESEARCH HAS BEGUN TO INVESTIGATE DNA METHYLATION DYNAMICS IN RELATION TO COCAINE USE DISORDERS. SPECIFICALLY, DNA METHYLATION MACHINERY, INCLUDING METHYLTRANSFERASES AND BINDING PROTEINS, ARE DYSREGULATED IN BRAIN REWARD PATHWAYS AFTER CHRONIC COCAINE EXPOSURE. IN ADDITION, NUMEROUS METHYLOME-WIDE AND CANDIDATE PROMOTER STUDIES HAVE IDENTIFIED DIFFERENTIAL METHYLATION, AT THE NUCLEOTIDE LEVEL, IN RODENT MODELS OF COCAINE ABUSE AND DRUG SEEKING BEHAVIOR. THIS REVIEW HIGHLIGHTS THE CURRENT PROGRESS IN THE FIELD OF COCAINE-RELATED METHYLATION, AND OFFERS CONSIDERATIONS FOR FUTURE RESEARCH. 2017 8 2576 28 EPIGENETICS OF FEAR, ANXIETY AND STRESS - FOCUS ON HISTONE MODIFICATIONS. FEAR-, ANXIETY- AND STRESS-RELATED DISORDERS ARE AMONG THE MOST FREQUENT MENTAL DISORDERS. GIVEN SUBSTANTIAL RATES OF INSUFFICIENT TREATMENT RESPONSE AND OFTEN A CHRONIC COURSE, A BETTER UNDER-STANDING OF THE PATHOMECHANISMS OF FEAR-, ANXIETY- AND STRESS-RELATED DISORDERS IS URGENTLY WARRANTED. EPIGENETIC MECHANISMS SUCH AS HISTONE MODIFICATIONS - POSITIONED AT THE INTERFACE BETWEEN THE BIOLOGICAL AND THE ENVIRONMENTAL LEVEL IN THE COMPLEX PATHOGENESIS OF MENTAL DISORDERS - MIGHT BE HIGHLY INFORMATIVE IN THIS CONTEXT. THE CURRENT STATE OF KNOWLEDGE ON HISTONE MODIFICATIONS, CHROMATIN-RELATED PHARMACOLOGY AND ANIMAL MODELS MODIFIED FOR GENES INVOLVED IN THE HISTONE-RELATED EPIGENETIC MA-CHINERY WILL BE REVIEWED WITH RESPECT TO FEAR-, ANXIETY- AND STRESS-RELATED STATES. RELEVANT STUDIES, PUBLISHED UNTIL 30TH JUNE 2022, WERE IDENTIFIED USING A MULTI-STEP SYSTEMATIC LITERATURE SEARCH OF THE PUB-MED AND WEB OF SCIENCE DATABASES. ANIMAL STUDIES POINT TOWARDS HISTONE MODIFICATIONS (E.G., H3K4ME3, H3K9ME1/2/3, H3K27ME2/3, H3K9AC, H3K14AC AND H4K5AC) TO BE DYNAMICALLY AND MOSTLY BRAIN REGION-, TASK- AND TIME-DEPENDENTLY ALTERED ON A GENOME-WIDE LEVEL OR GENE-SPECIFICALLY (E.G., BDNF) IN MODELS OF FEAR CONDITIONING, RETRIEVAL AND EXTINCTION, ACUTE AND (SUB-)CHRONIC STRESS. SINGULAR AND UNDERPOWERED STUDIES ON HISTONE MODIFICATIONS IN HUMAN FEAR-, ANXIETY- OR STRESS-RELATED PHENOTYPES ARE CURRENTLY RESTRICTED TO THE PHENOTYPE OF PTSD. PROVIDED CONSISTENT VALIDATION IN HUMAN PHENOTYPES, EPIGENETIC BIOMARKERS MIGHT ULTIMATELY INFORM INDICATED PREVENTIVE INTERVENTIONS AS WELL AS PERSONALIZED TREATMENT APPROACHES, AND COULD INSPIRE FUTURE INNOVATIVE PHARMACOLOGICAL TREATMENT OPTIONS TARGETING THE EPIGENETIC MACHINERY IMPROVING TREATMENT RESPONSE IN FEAR-, ANXIETY- AND STRESS RELATED DISORDERS. 2023 9 6517 26 TRANSCRIPTIONAL AND EPIGENETIC MECHANISMS OF ADDICTION. INVESTIGATIONS OF LONG-TERM CHANGES IN BRAIN STRUCTURE AND FUNCTION THAT ACCOMPANY CHRONIC EXPOSURE TO DRUGS OF ABUSE SUGGEST THAT ALTERATIONS IN GENE REGULATION CONTRIBUTE SUBSTANTIALLY TO THE ADDICTIVE PHENOTYPE. HERE, WE REVIEW MULTIPLE MECHANISMS BY WHICH DRUGS ALTER THE TRANSCRIPTIONAL POTENTIAL OF GENES. THESE MECHANISMS RANGE FROM THE MOBILIZATION OR REPRESSION OF THE TRANSCRIPTIONAL MACHINERY - INCLUDING THE TRANSCRIPTION FACTORS DELTAFOSB, CYCLIC AMP-RESPONSIVE ELEMENT BINDING PROTEIN (CREB) AND NUCLEAR FACTOR-KAPPAB (NF-KAPPAB) - TO EPIGENETICS - INCLUDING ALTERATIONS IN THE ACCESSIBILITY OF GENES WITHIN THEIR NATIVE CHROMATIN STRUCTURE INDUCED BY HISTONE TAIL MODIFICATIONS AND DNA METHYLATION, AND THE REGULATION OF GENE EXPRESSION BY NON-CODING RNAS. INCREASING EVIDENCE IMPLICATES THESE VARIOUS MECHANISMS OF GENE REGULATION IN THE LASTING CHANGES THAT DRUGS OF ABUSE INDUCE IN THE BRAIN, AND OFFERS NOVEL INROADS FOR ADDICTION THERAPY. 2011 10 3952 31 LOCUS-SPECIFIC EPIGENETIC REMODELING CONTROLS ADDICTION- AND DEPRESSION-RELATED BEHAVIORS. CHRONIC EXPOSURE TO DRUGS OF ABUSE OR STRESS REGULATES TRANSCRIPTION FACTORS, CHROMATIN-MODIFYING ENZYMES AND HISTONE POST-TRANSLATIONAL MODIFICATIONS IN DISCRETE BRAIN REGIONS. GIVEN THE PROMISCUITY OF THE ENZYMES INVOLVED, IT HAS NOT YET BEEN POSSIBLE TO OBTAIN DIRECT CAUSAL EVIDENCE TO IMPLICATE THE REGULATION OF TRANSCRIPTION AND CONSEQUENT BEHAVIORAL PLASTICITY BY CHROMATIN REMODELING THAT OCCURS AT A SINGLE GENE. WE INVESTIGATED THE MECHANISM LINKING CHROMATIN DYNAMICS TO NEUROBIOLOGICAL PHENOMENA BY APPLYING ENGINEERED TRANSCRIPTION FACTORS TO SELECTIVELY MODIFY CHROMATIN AT A SPECIFIC MOUSE GENE IN VIVO. WE FOUND THAT HISTONE METHYLATION OR ACETYLATION AT THE FOSB LOCUS IN NUCLEUS ACCUMBENS, A BRAIN REWARD REGION, WAS SUFFICIENT TO CONTROL DRUG- AND STRESS-EVOKED TRANSCRIPTIONAL AND BEHAVIORAL RESPONSES VIA INTERACTIONS WITH THE ENDOGENOUS TRANSCRIPTIONAL MACHINERY. THIS APPROACH ALLOWED US TO RELATE THE EPIGENETIC LANDSCAPE AT A GIVEN GENE DIRECTLY TO REGULATION OF ITS EXPRESSION AND TO ITS SUBSEQUENT EFFECTS ON REWARD BEHAVIOR. 2014 11 6806 33 [EPIGENETICS AND DRUG ADDICTION: A FOCUS ON MECP2 AND ON HISTONE ACETYLATION]. CHRONIC DRUG EXPOSURE ALTERS GENE EXPRESSION IN THE BRAIN, WHICH IS BELIEVED TO UNDERLIE COMPULSIVE DRUG SEEKING AND DRUG TAKING BEHAVIOR. RECENT EVIDENCE SHOWS THAT DRUG-INDUCED LONG-TERM NEUROADAPTATIONS IN THE BRAIN ARE MEDIATED IN PART BY EPIGENETIC MECHANISMS. BY REMODELING CHROMATIN, THIS TYPE OF REGULATION CONTRIBUTES TO DRUG-INDUCED SYNAPTIC PLASTICITY THAT TRANSLATES INTO BEHAVIORAL MODIFICATIONS. HOW DRUG-INDUCED ALTERATIONS IN DNA METHYLATION REGULATE GENE EXPRESSION IS REVIEWED HERE, WITH A FOCUS ON MECP2, A PROTEIN BINDING METHYLATED DNA. THE IMPORTANCE OF HISTONE MODIFICATIONS, ESPECIALLY ACETYLATION IS ALSO DISCUSSED, WITH AN EMPHASIS ON THE EFFECTS OF INHIBITORS OF HISTONE DEACETYLASES ON DRUG-INDUCED BEHAVIORAL CHANGES. THE PRECISE IDENTIFICATION OF THE EPIGENETIC MECHANISMS THAT ARE UNDER THE CONTROL OF DRUGS OF ABUSE MAY HELP TO UNCOVER NOVEL TARGETS FOR THE TREATMENT OF DRUG SEEKING AND RELAPSE. 2015 12 3972 30 LONG-TERM BEHAVIORAL AND CELL-TYPE-SPECIFIC MOLECULAR EFFECTS OF EARLY LIFE STRESS ARE MEDIATED BY H3K79ME2 DYNAMICS IN MEDIUM SPINY NEURONS. ANIMALS SUSCEPTIBLE TO CHRONIC SOCIAL DEFEAT STRESS (CSDS) EXHIBIT DEPRESSION-RELATED BEHAVIORS, WITH ABERRANT TRANSCRIPTION ACROSS SEVERAL LIMBIC BRAIN REGIONS, MOST NOTABLY IN THE NUCLEUS ACCUMBENS (NAC). EARLY LIFE STRESS (ELS) PROMOTES SUSCEPTIBILITY TO CSDS IN ADULTHOOD, BUT ASSOCIATED ENDURING CHANGES IN TRANSCRIPTIONAL CONTROL MECHANISMS IN THE NAC HAVE NOT YET BEEN INVESTIGATED. IN THIS STUDY, WE EXAMINED LONG-LASTING CHANGES TO HISTONE MODIFICATIONS IN THE NAC OF MALE AND FEMALE MICE EXPOSED TO ELS. DIMETHYLATION OF LYSINE 79 OF HISTONE H3 (H3K79ME2) AND THE ENZYMES (DOT1L AND KDM2B) THAT CONTROL THIS MODIFICATION ARE ENRICHED IN D2-TYPE MEDIUM SPINY NEURONS AND ARE SHOWN TO BE CRUCIAL FOR THE EXPRESSION OF ELS-INDUCED STRESS SUSCEPTIBILITY. WE MAPPED THE SITE-SPECIFIC REGULATION OF THIS HISTONE MARK GENOME WIDE TO REVEAL THE TRANSCRIPTIONAL NETWORKS IT MODULATES. FINALLY, SYSTEMIC DELIVERY OF A SMALL MOLECULE INHIBITOR OF DOT1L REVERSED ELS-INDUCED BEHAVIORAL DEFICITS, INDICATING THE CLINICAL RELEVANCE OF THIS EPIGENETIC MECHANISM. 2021 13 5675 25 SHIFTS IN PODOCYTE HISTONE H3K27ME3 REGULATE MOUSE AND HUMAN GLOMERULAR DISEASE. HISTONE PROTEIN MODIFICATIONS CONTROL FATE DETERMINATION DURING NORMAL DEVELOPMENT AND DEDIFFERENTIATION DURING DISEASE. HERE, WE SET OUT TO DETERMINE THE EXTENT TO WHICH DYNAMIC CHANGES TO HISTONES AFFECT THE DIFFERENTIATED PHENOTYPE OF ORDINARILY QUIESCENT ADULT GLOMERULAR PODOCYTES. TO DO THIS, WE EXAMINED THE CONSEQUENCES OF SHIFTING THE BALANCE OF THE REPRESSIVE HISTONE H3 LYSINE 27 TRIMETHYLATION (H3K27ME3) MARK IN PODOCYTES. ADRIAMYCIN NEPHROTOXICITY AND SUBTOTAL NEPHRECTOMY (SNX) STUDIES INDICATED THAT DELETION OF THE HISTONE METHYLATING ENZYME EZH2 FROM PODOCYTES DECREASED H3K27ME3 LEVELS AND SENSITIZED MICE TO GLOMERULAR DISEASE. H3K27ME3 WAS ENRICHED AT THE PROMOTER REGION OF THE NOTCH LIGAND JAG1 IN PODOCYTES, AND DEREPRESSION OF JAG1 BY EZH2 INHIBITION OR KNOCKDOWN FACILITATED PODOCYTE DEDIFFERENTIATION. CONVERSELY, INHIBITION OF THE JUMONJI C DOMAIN-CONTAINING DEMETHYLASES JMJD3 AND UTX INCREASED THE H3K27ME3 CONTENT OF PODOCYTES AND ATTENUATED GLOMERULAR DISEASE IN ADRIAMYCIN NEPHROTOXICITY, SNX, AND DIABETES. PODOCYTES IN GLOMERULI FROM HUMANS WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS OR DIABETIC NEPHROPATHY EXHIBITED DIMINISHED H3K27ME3 AND HEIGHTENED UTX CONTENT. ANALOGOUS TO HUMAN DISEASE, INHIBITION OF JMJD3 AND UTX ABATED NEPHROPATHY PROGRESSION IN MICE WITH ESTABLISHED GLOMERULAR INJURY AND REDUCED H3K27ME3 LEVELS. TOGETHER, THESE FINDINGS INDICATE THAT OSTENSIBLY STABLE CHROMATIN MODIFICATIONS CAN BE DYNAMICALLY REGULATED IN QUIESCENT CELLS AND THAT EPIGENETIC REPROGRAMMING CAN IMPROVE OUTCOMES IN GLOMERULAR DISEASE BY REPRESSING THE REACTIVATION OF DEVELOPMENTAL PATHWAYS. 2018 14 2318 28 EPIGENETIC REGULATION OF GABAERGIC DIFFERENTIATION IN THE DEVELOPING BRAIN. IN THE VERTEBRATE BRAIN, GABAERGIC CELL DEVELOPMENT AND NEUROTRANSMISSION ARE IMPORTANT FOR THE ESTABLISHMENT OF NEURAL CIRCUITS. VARIOUS INTRINSIC AND EXTRINSIC FACTORS HAVE BEEN IDENTIFIED TO AFFECT GABAERGIC NEUROGENESIS. HOWEVER, LITTLE IS KNOWN ABOUT THE EPIGENETIC CONTROL OF GABAERGIC DIFFERENTIATION IN THE DEVELOPING BRAIN. HERE, WE REPORT THAT THE NUMBER OF GABAERGIC NEURONS DYNAMICALLY CHANGES DURING THE EARLY TECTAL DEVELOPMENT IN THE XENOPUS BRAIN. THE PERCENTAGE OF GABAERGIC NEURONS IS RELATIVELY UNCHANGED DURING THE EARLY STAGES FROM STAGE 40 TO 46 BUT SIGNIFICANTLY DECREASED FROM STAGE 46 TO 48 TADPOLES. INTERESTINGLY, THE HISTONE ACETYLATION OF H3K9 IS DEVELOPMENTALLY DECREASED FROM STAGE 42 TO 48 (ABOUT 3.5 DAYS). CHRONIC APPLICATION OF VALPROATE ACID (VPA), A BROAD-SPECTRUM HISTONE DEACETYLASE (HDAC) INHIBITOR, AT STAGE 46 FOR 48 H INCREASES THE ACETYLATION OF H3K9 AND THE NUMBER OF GABAERGIC CELLS IN THE OPTIC TECTUM. VPA TREATMENT ALSO REDUCES APOPTOTIC CELLS. ELECTROPHYSIOLOGICAL RECORDINGS SHOW THAT A VPA INDUCES AN INCREASE IN THE FREQUENCY OF MIPSCS AND NO CHANGES IN THE AMPLITUDE. BEHAVIORAL STUDIES REVEAL THAT VPA DECREASES SWIMMING ACTIVITY AND VISUALLY GUIDED AVOIDANCE BEHAVIOR. THESE FINDINGS EXTEND OUR UNDERSTANDING OF HISTONE MODIFICATION IN THE GABAERGIC DIFFERENTIATION AND NEUROTRANSMISSION DURING EARLY BRAIN DEVELOPMENT. 2022 15 1549 25 DNA METHYLATION IN THE HUMAN CEREBRAL CORTEX IS DYNAMICALLY REGULATED THROUGHOUT THE LIFE SPAN AND INVOLVES DIFFERENTIATED NEURONS. THE ROLE OF DNA CYTOSINE METHYLATION, AN EPIGENETIC REGULATOR OF CHROMATIN STRUCTURE AND FUNCTION, DURING NORMAL AND PATHOLOGICAL BRAIN DEVELOPMENT AND AGING REMAINS UNCLEAR. HERE, WE EXAMINED BY METHYLIGHT PCR THE DNA METHYLATION STATUS AT 50 LOCI, ENCOMPASSING PRIMARILY 5' CPG ISLANDS OF GENES RELATED TO CNS GROWTH AND DEVELOPMENT, IN TEMPORAL NEOCORTEX OF 125 SUBJECTS RANGING IN AGE FROM 17 WEEKS OF GESTATION TO 104 YEARS OLD. TWO PSYCHIATRIC DISEASE COHORTS--DEFINED BY CHRONIC NEURODEGENERATION (ALZHEIMER'S) OR LACK THEREOF (SCHIZOPHRENIA)--WERE INCLUDED. A ROBUST AND PROGRESSIVE RISE IN DNA METHYLATION LEVELS ACROSS THE LIFESPAN WAS OBSERVED FOR 8/50 LOCI (GABRA2, GAD1, HOXA1, NEUROD1, NEUROD2, PGR, STK11, SYK) TYPICALLY IN CONJUNCTION WITH DECLINING LEVELS OF THE CORRESPONDING MRNAS. ANOTHER 16 LOCI WERE DEFINED BY A SHARP RISE IN DNA METHYLATION LEVELS WITHIN THE FIRST FEW MONTHS OR YEARS AFTER BIRTH. DISEASE-ASSOCIATED CHANGES WERE LIMITED TO 2/50 LOCI IN THE ALZHEIMER'S COHORT, WHICH APPEARED TO REFLECT AN ACCELERATION OF THE AGE-RELATED CHANGE IN NORMAL BRAIN. ADDITIONALLY, METHYLATION STUDIES ON SORTED NUCLEI PROVIDED EVIDENCE FOR BIDIRECTIONAL METHYLATION EVENTS IN CORTICAL NEURONS DURING THE TRANSITION FROM CHILDHOOD TO ADVANCED AGE, AS REFLECTED BY SIGNIFICANT INCREASES AT 3, AND A DECREASE AT 1 OF 10 LOCI. FURTHERMORE, THE DNMT3A DE NOVO DNA METHYL-TRANSFERASE WAS EXPRESSED ACROSS ALL AGES, INCLUDING A SUBSET OF NEURONS RESIDING IN LAYERS III AND V OF THE MATURE CORTEX. THEREFORE, DNA METHYLATION IS DYNAMICALLY REGULATED IN THE HUMAN CEREBRAL CORTEX THROUGHOUT THE LIFESPAN, INVOLVES DIFFERENTIATED NEURONS, AND AFFECTS A SUBSTANTIAL PORTION OF GENES PREDOMINANTLY BY AN AGE-RELATED INCREASE. 2007 16 1562 30 DNA METHYLATION OF ENHANCER ELEMENTS IN MYELOID NEOPLASMS: THINK OUTSIDE THE PROMOTERS? GENE REGULATION THROUGH DNA METHYLATION IS A WELL DESCRIBED PHENOMENON THAT HAS A PROMINENT ROLE IN PHYSIOLOGICAL AND PATHOLOGICAL CELL-STATES. THIS EPIGENETIC MODIFICATION IS USUALLY GROUPED IN REGIONS DENOMINATED CPG ISLANDS, WHICH FREQUENTLY CO-LOCALIZE WITH GENE PROMOTERS, SILENCING THE TRANSCRIPTION OF THOSE GENES. RECENT GENOME-WIDE DNA METHYLATION STUDIES HAVE CHALLENGED THIS PARADIGM, DEMONSTRATING THAT DNA METHYLATION OF REGULATORY REGIONS OUTSIDE PROMOTERS IS ABLE TO INFLUENCE CELL-TYPE SPECIFIC GENE EXPRESSION PROGRAMS UNDER PHYSIOLOGIC OR PATHOLOGIC CONDITIONS. COUPLING GENOME-WIDE DNA METHYLATION ASSAYS WITH HISTONE MARK ANNOTATION HAS ALLOWED FOR THE IDENTIFICATION OF SPECIFIC EPIGENOMIC CHANGES THAT AFFECT ENHANCER REGULATORY REGIONS, REVEALING AN ADDITIONAL LAYER OF COMPLEXITY TO THE EPIGENETIC REGULATION OF GENE EXPRESSION. IN THIS REVIEW, WE SUMMARIZE THE NOVEL EVIDENCE FOR THE MOLECULAR AND BIOLOGICAL REGULATION OF DNA METHYLATION IN ENHANCER REGIONS AND THE DYNAMISM OF THESE CHANGES CONTRIBUTING TO THE FINE-TUNING OF GENE EXPRESSION. WE ALSO ANALYZE THE CONTRIBUTION OF ENHANCER DNA METHYLATION ON THE EXPRESSION OF RELEVANT GENES IN ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOPROLIFERATIVE NEOPLASMS. THE CHARACTERIZATION OF THE ABERRANT ENHANCER DNA METHYLATION PROVIDES NOT ONLY A NOVEL PATHOGENIC MECHANISM FOR DIFFERENT TUMORS BUT ALSO HIGHLIGHTS NOVEL POTENTIAL THERAPEUTIC TARGETS FOR MYELOID DERIVED NEOPLASMS. 2019 17 2144 29 EPIGENETIC LANDSCAPE OF STRESS SURFEIT DISORDERS: KEY ROLE FOR DNA METHYLATION DYNAMICS. CHRONIC EXPOSURE TO STRESS THROUGHOUT LIFESPAN ALTERS BRAIN STRUCTURE AND FUNCTION, INDUCING A MALADAPTIVE RESPONSE TO ENVIRONMENTAL STIMULI, THAT CAN CONTRIBUTE TO THE DEVELOPMENT OF A PATHOLOGICAL PHENOTYPE. STUDIES HAVE SHOWN THAT HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS DYSFUNCTION IS ASSOCIATED WITH VARIOUS NEUROPSYCHIATRIC DISORDERS, INCLUDING MAJOR DEPRESSIVE, ALCOHOL USE AND POST-TRAUMATIC STRESS DISORDERS. DOWNSTREAM ACTORS OF THE HPA AXIS, GLUCOCORTICOIDS ARE CRITICAL MEDIATORS OF THE STRESS RESPONSE AND EXERT THEIR FUNCTION THROUGH SPECIFIC RECEPTORS, I.E., THE GLUCOCORTICOID RECEPTOR (GR), HIGHLY EXPRESSED IN STRESS/REWARD-INTEGRATIVE PATHWAYS. GRS ARE LIGAND-ACTIVATED TRANSCRIPTION FACTORS THAT RECRUIT EPIGENETIC ACTORS TO REGULATE GENE EXPRESSION VIA DNA METHYLATION, ALTERING CHROMATIN STRUCTURE AND THUS SHAPING THE RESPONSE TO STRESS. THE DYNAMIC INTERPLAY BETWEEN STRESS RESPONSE AND EPIGENETIC MODIFIERS SUGGEST DNA METHYLATION PLAYS A KEY ROLE IN THE DEVELOPMENT OF STRESS SURFEIT DISORDERS. 2021 18 883 39 CHRONIC COCAINE-REGULATED EPIGENOMIC CHANGES IN MOUSE NUCLEUS ACCUMBENS. BACKGROUND: INCREASING EVIDENCE SUPPORTS A ROLE FOR ALTERED GENE EXPRESSION IN MEDIATING THE LASTING EFFECTS OF COCAINE ON THE BRAIN, AND RECENT WORK HAS DEMONSTRATED THE INVOLVEMENT OF CHROMATIN MODIFICATIONS IN THESE ALTERATIONS. HOWEVER, ALL SUCH STUDIES TO DATE HAVE BEEN RESTRICTED BY THEIR RELIANCE ON MICROARRAY TECHNOLOGIES THAT HAVE INTRINSIC LIMITATIONS. RESULTS: WE USE NEXT GENERATION SEQUENCING METHODS, RNA-SEQ AND CHIP-SEQ FOR RNA POLYMERASE II AND SEVERAL HISTONE METHYLATION MARKS, TO OBTAIN A MORE COMPLETE VIEW OF COCAINE-INDUCED CHANGES IN GENE EXPRESSION AND ASSOCIATED ADAPTATIONS IN NUMEROUS MODES OF CHROMATIN REGULATION IN THE MOUSE NUCLEUS ACCUMBENS, A KEY BRAIN REWARD REGION. WE DEMONSTRATE AN UNEXPECTEDLY LARGE NUMBER OF PRE-MRNA SPLICING ALTERATIONS IN RESPONSE TO REPEATED COCAINE TREATMENT. IN ADDITION, WE IDENTIFY COMBINATIONS OF CHROMATIN CHANGES, OR SIGNATURES, THAT CORRELATE WITH COCAINE-DEPENDENT REGULATION OF GENE EXPRESSION, INCLUDING THOSE INVOLVING PRE-MRNA ALTERNATIVE SPLICING. THROUGH BIOINFORMATIC PREDICTION AND BIOLOGICAL VALIDATION, WE IDENTIFY ONE PARTICULAR SPLICING FACTOR, A2BP1(RBFOX1/FOX-1), WHICH IS ENRICHED AT GENES THAT DISPLAY CERTAIN CHROMATIN SIGNATURES AND CONTRIBUTES TO DRUG-INDUCED BEHAVIORAL ABNORMALITIES. TOGETHER, THIS DELINEATION OF THE COCAINE-INDUCED EPIGENOME IN THE NUCLEUS ACCUMBENS REVEALS SEVERAL NOVEL MODES OF REGULATION BY WHICH COCAINE ALTERS THE BRAIN. CONCLUSIONS: WE ESTABLISH COMBINATORIAL CHROMATIN AND TRANSCRIPTIONAL PROFILES IN MOUSE NUCLEUS ACCUMBENS AFTER REPEATED COCAINE TREATMENT. THESE RESULTS SERVE AS AN IMPORTANT RESOURCE FOR THE FIELD AND PROVIDE A TEMPLATE FOR THE ANALYSIS OF OTHER SYSTEMS TO REVEAL NEW TRANSCRIPTIONAL AND EPIGENETIC MECHANISMS OF NEURONAL REGULATION. 2014 19 3375 33 HISTONE POSTTRANSLATIONAL MODIFICATIONS PREDICT SPECIFIC ALTERNATIVE EXON SUBTYPES IN MAMMALIAN BRAIN. A COMPELLING BODY OF LITERATURE, BASED ON NEXT GENERATION CHROMATIN IMMUNOPRECIPITATION AND RNA SEQUENCING OF REWARD BRAIN REGIONS INDICATES THAT THE REGULATION OF THE EPIGENETIC LANDSCAPE LIKELY UNDERLIES CHRONIC DRUG ABUSE AND ADDICTION. IT IS NOW CRITICAL TO DEVELOP HIGHLY INNOVATIVE COMPUTATIONAL STRATEGIES TO REVEAL THE RELEVANT REGULATORY TRANSCRIPTIONAL MECHANISMS THAT MAY UNDERLIE NEUROPSYCHIATRIC DISEASE. WE HAVE ANALYZED CHROMATIN REGULATION OF ALTERNATIVE SPLICING, WHICH IS IMPLICATED IN COCAINE EXPOSURE IN MICE. RECENT LITERATURE HAS DESCRIBED CHROMATIN-REGULATED ALTERNATIVE SPLICING, SUGGESTING A NOVEL FUNCTION FOR DRUG-INDUCED NEUROEPIGENETIC REMODELING. HOWEVER, THE EXTENT OF THE GENOME-WIDE ASSOCIATION BETWEEN PARTICULAR HISTONE MODIFICATIONS AND ALTERNATIVE SPLICING REMAINS UNEXPLORED. TO ADDRESS THIS, WE HAVE DEVELOPED NOVEL COMPUTATIONAL APPROACHES TO MODEL THE ASSOCIATION BETWEEN ALTERNATIVE SPLICING AND HISTONE POSTTRANSLATIONAL MODIFICATIONS IN THE NUCLEUS ACCUMBENS (NAC), A BRAIN REWARD REGION. USING CLASSICAL STATISTICAL METHODS AND MACHINE LEARNING TO COMBINE CHIP-SEQ AND RNA-SEQ DATA, WE FOUND THAT SPECIFIC HISTONE MODIFICATIONS ARE STRONGLY ASSOCIATED WITH VARIOUS ASPECTS OF DIFFERENTIAL SPLICING. H3K36ME3 AND H3K4ME1 HAVE THE STRONGEST ASSOCIATION WITH SPLICING INDICATING THEY PLAY A SIGNIFICANT ROLE IN ALTERNATIVE SPLICING IN BRAIN REWARD TISSUE. 2017 20 775 36 CELL TYPE-SPECIFIC WHOLE-GENOME LANDSCAPE OF DELTAFOSB BINDING IN THE NUCLEUS ACCUMBENS AFTER CHRONIC COCAINE EXPOSURE. BACKGROUND: THE ABILITY OF NEURONS TO RESPOND TO EXTERNAL STIMULI INVOLVES ADAPTATIONS OF GENE EXPRESSION. INDUCTION OF THE TRANSCRIPTION FACTOR DELTAFOSB IN THE NUCLEUS ACCUMBENS, A KEY BRAIN REWARD REGION, IS IMPORTANT FOR THE DEVELOPMENT OF DRUG ADDICTION. HOWEVER, A COMPREHENSIVE MAP OF DELTAFOSB'S GENE TARGETS HAS NOT YET BEEN GENERATED. METHODS: WE USED CUT&RUN (CLEAVAGE UNDER TARGETS AND RELEASE USING NUCLEASE) TO MAP THE GENOME-WIDE CHANGES IN DELTAFOSB BINDING IN THE 2 MAIN TYPES OF NUCLEUS ACCUMBENS NEURONS-D1 OR D2 MEDIUM SPINY NEURONS-AFTER CHRONIC COCAINE EXPOSURE. TO ANNOTATE GENOMIC REGIONS OF DELTAFOSB BINDING SITES, WE ALSO EXAMINED THE DISTRIBUTIONS OF SEVERAL HISTONE MODIFICATIONS. RESULTING DATASETS WERE LEVERAGED FOR MULTIPLE BIOINFORMATIC ANALYSES. RESULTS: THE MAJORITY OF DELTAFOSB PEAKS OCCUR OUTSIDE PROMOTER REGIONS, INCLUDING INTERGENIC REGIONS, AND ARE SURROUNDED BY EPIGENETIC MARKS INDICATIVE OF ACTIVE ENHANCERS. BRG1, THE CORE SUBUNIT OF THE SWI/SNF CHROMATIN REMODELING COMPLEX, OVERLAPS WITH DELTAFOSB PEAKS, A FINDING CONSISTENT WITH EARLIER STUDIES OF DELTAFOSB'S INTERACTING PROTEINS. CHRONIC COCAINE USE INDUCES BROAD CHANGES IN DELTAFOSB BINDING IN BOTH D1 AND D2 NUCLEUS ACCUMBENS MEDIUM SPINY NEURONS OF MALE AND FEMALE MICE. IN ADDITION, IN SILICO ANALYSES PREDICT THAT DELTAFOSB COOPERATIVELY REGULATES GENE EXPRESSION WITH HOMEOBOX AND T-BOX TRANSCRIPTION FACTORS. CONCLUSIONS: THESE NOVEL FINDINGS UNCOVER KEY ELEMENTS OF DELTAFOSB'S MOLECULAR MECHANISMS IN TRANSCRIPTIONAL REGULATION AT BASELINE AND IN RESPONSE TO CHRONIC COCAINE EXPOSURE. FURTHER CHARACTERIZATION OF DELTAFOSB'S COLLABORATIVE TRANSCRIPTIONAL AND CHROMATIN PARTNERS SPECIFICALLY IN D1 AND D2 MEDIUM SPINY NEURONS WILL REVEAL A BROADER PICTURE OF THE FUNCTION OF DELTAFOSB AND THE MOLECULAR BASIS OF DRUG ADDICTION. 2023